Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2012

Open Access 01-12-2012 | Research article

Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography

Authors: Li Zhang, Qiao-ying LI, Yun-you Duan, Guo-zhen Yan, Yi-lin Yang, Rui-jing Yang

Published in: BMC Medical Informatics and Decision Making | Issue 1/2012

Login to get access

Abstract

Background

Artificial neural networks (ANNs) are widely studied for evaluating diseases. This paper discusses the intelligence mode of an ANN in grading the diagnosis of liver fibrosis by duplex ultrasonogaphy.

Methods

239 patients who were confirmed as having liver fibrosis or cirrhosis by ultrasound guided liver biopsy were investigated in this study. We quantified ultrasonographic parameters as significant parameters using a data optimization procedure applied to an ANN. 179 patients were typed at random as the training group; 60 additional patients were consequently enrolled as the validating group. Performance of the ANN was evaluated according to accuracy, sensitivity, specificity, Youden’s index and receiver operating characteristic (ROC) analysis.

Results

5 ultrasonographic parameters; i.e., the liver parenchyma, thickness of spleen, hepatic vein (HV) waveform, hepatic artery pulsatile index (HAPI) and HV damping index (HVDI), were enrolled as the input neurons in the ANN model. The sensitivity, specificity and accuracy of the ANN model for quantitative diagnosis of liver fibrosis were 95.0%, 85.0% and 88.3%, respectively. The Youden’s index (YI) was 0.80.

Conclusions

The established ANN model had good sensitivity and specificity in quantitative diagnosis of hepatic fibrosis or liver cirrhosis. Our study suggests that the ANN model based on duplex ultrasound may help non-invasive grading diagnosis of liver fibrosis in clinical practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993, 328: 1828-1835. 10.1056/NEJM199306243282508.CrossRefPubMed Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993, 328: 1828-1835. 10.1056/NEJM199306243282508.CrossRefPubMed
2.
go back to reference Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986, 2: 165-173. 10.1016/S0168-8278(86)80075-7.CrossRefPubMed Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986, 2: 165-173. 10.1016/S0168-8278(86)80075-7.CrossRefPubMed
3.
go back to reference Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med. 2001, 344: 495-500. 10.1056/NEJM200102153440706.CrossRefPubMed Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med. 2001, 344: 495-500. 10.1056/NEJM200102153440706.CrossRefPubMed
4.
go back to reference Narasimhan G, Sargios TN, Kalakuntla R, Homel P, Clain DJ, Theise ND, Bodenheimer HC, Min AD: Treatment rates in patients with chronic hepatitis C after liver biopsy. J Viral Hepat. 2006, 13: 783-786. 10.1111/j.1365-2893.2006.00763.x.CrossRefPubMed Narasimhan G, Sargios TN, Kalakuntla R, Homel P, Clain DJ, Theise ND, Bodenheimer HC, Min AD: Treatment rates in patients with chronic hepatitis C after liver biopsy. J Viral Hepat. 2006, 13: 783-786. 10.1111/j.1365-2893.2006.00763.x.CrossRefPubMed
5.
go back to reference Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity asymptomatic chronic active hepatitis. Hepatology. 1981, 1: 431-435. 10.1002/hep.1840010511.CrossRefPubMed Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity asymptomatic chronic active hepatitis. Hepatology. 1981, 1: 431-435. 10.1002/hep.1840010511.CrossRefPubMed
6.
go back to reference Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA: A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparism with morphometric studies. Hepatology. 1994, 20: 349-355. 10.1002/hep.1840200213.CrossRefPubMed Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA: A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparism with morphometric studies. Hepatology. 1994, 20: 349-355. 10.1002/hep.1840200213.CrossRefPubMed
7.
go back to reference Dayhoff JE, Deleo JM: Artificial neural network: opening the black box. Cancer. 2001, 91: 1615-1635. 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L.CrossRefPubMed Dayhoff JE, Deleo JM: Artificial neural network: opening the black box. Cancer. 2001, 91: 1615-1635. 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L.CrossRefPubMed
8.
go back to reference Green M, Bjork J, Forberg J, Ekelund U, Edenbrandt L, Ohlsson M: Comparison between neural networks and multiple logistic regression to predict acute coronary syndrome in the emergency room. Artif Intell Med. 2006, 38: 305-318. 10.1016/j.artmed.2006.07.006.CrossRefPubMed Green M, Bjork J, Forberg J, Ekelund U, Edenbrandt L, Ohlsson M: Comparison between neural networks and multiple logistic regression to predict acute coronary syndrome in the emergency room. Artif Intell Med. 2006, 38: 305-318. 10.1016/j.artmed.2006.07.006.CrossRefPubMed
9.
go back to reference Abbod MF, Catto JW, Linkens DA, Hamdy FC: Application of artificial intelligence to the management of urological cancer. J Urol. 2007, 178: 1150-1156. 10.1016/j.juro.2007.05.122.CrossRefPubMed Abbod MF, Catto JW, Linkens DA, Hamdy FC: Application of artificial intelligence to the management of urological cancer. J Urol. 2007, 178: 1150-1156. 10.1016/j.juro.2007.05.122.CrossRefPubMed
10.
go back to reference Cross SS, Harrison RF, Kennedy RL: Introduction to neural networks. Lancet. 1995, 346: 1075-1079. 10.1016/S0140-6736(95)91746-2.CrossRefPubMed Cross SS, Harrison RF, Kennedy RL: Introduction to neural networks. Lancet. 1995, 346: 1075-1079. 10.1016/S0140-6736(95)91746-2.CrossRefPubMed
11.
go back to reference Raoufy MR, Vahdani P, Alavian SM, Fekri S, Eftekhari P, Gharibzadeh S: A novel method for diagnosing cirrhosis in patients with chronic hepatitis B: artificial neural network approach. J Med Syst. 2011, 35: 121-126. 10.1007/s10916-009-9348-8.CrossRefPubMed Raoufy MR, Vahdani P, Alavian SM, Fekri S, Eftekhari P, Gharibzadeh S: A novel method for diagnosing cirrhosis in patients with chronic hepatitis B: artificial neural network approach. J Med Syst. 2011, 35: 121-126. 10.1007/s10916-009-9348-8.CrossRefPubMed
12.
go back to reference Wang D, Wang Q, Shan F, Liu B, Lu C: Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infect Dis. 2010, 10: 251-10.1186/1471-2334-10-251.CrossRefPubMedPubMedCentral Wang D, Wang Q, Shan F, Liu B, Lu C: Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infect Dis. 2010, 10: 251-10.1186/1471-2334-10-251.CrossRefPubMedPubMedCentral
13.
go back to reference Dariani S, Keshavarz M, Parviz M, Raoufy MR, Gharibzadeh S: Modeling force-velocity relation in skeletal muscle isotonic contraction using an artificial neural network. Biosystems. 2007, 90: 529-534. 10.1016/j.biosystems.2006.12.004.CrossRefPubMed Dariani S, Keshavarz M, Parviz M, Raoufy MR, Gharibzadeh S: Modeling force-velocity relation in skeletal muscle isotonic contraction using an artificial neural network. Biosystems. 2007, 90: 529-534. 10.1016/j.biosystems.2006.12.004.CrossRefPubMed
14.
go back to reference Dietrich CF, Lee JH, Gottschalk R, Herrmann G, Sarrazin C, Caspary WF, Zeuzem S: Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol. 1998, 171: 437-443.CrossRefPubMed Dietrich CF, Lee JH, Gottschalk R, Herrmann G, Sarrazin C, Caspary WF, Zeuzem S: Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. AJR Am J Roentgenol. 1998, 171: 437-443.CrossRefPubMed
15.
go back to reference Castera L, Pinzani M: Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. Gut. 2010, 59: 861-866. 10.1136/gut.2010.214650.CrossRefPubMed Castera L, Pinzani M: Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. Gut. 2010, 59: 861-866. 10.1136/gut.2010.214650.CrossRefPubMed
16.
go back to reference Bedossa P, Darge`re D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003, 38: 1449e57-CrossRef Bedossa P, Darge`re D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003, 38: 1449e57-CrossRef
17.
go back to reference Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986, 1: 523e5- Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986, 1: 523e5-
18.
go back to reference Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002, 97: 2614e18-CrossRef Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002, 97: 2614e18-CrossRef
19.
go back to reference Rousselet MC, Michalak S, Dupré F, Croué A, Bedossa P, Saint-André JP, Calès P: Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005, 41: 257e64-CrossRef Rousselet MC, Michalak S, Dupré F, Croué A, Bedossa P, Saint-André JP, Calès P: Sources of variability in histological scoring of chronic viral hepatitis. Hepatology. 2005, 41: 257e64-CrossRef
20.
go back to reference Hunt D, Haynes R, Hanna S, Smith K: Effects of computer-based decision support systems on physician performance and patient outcomes. JAMA. 1998, 280: 1339-1346. 10.1001/jama.280.15.1339.CrossRefPubMed Hunt D, Haynes R, Hanna S, Smith K: Effects of computer-based decision support systems on physician performance and patient outcomes. JAMA. 1998, 280: 1339-1346. 10.1001/jama.280.15.1339.CrossRefPubMed
21.
go back to reference Blumenthal D: The future of quality measurement and management in a transforming health care system. JAMA. 1997, 278: 1622-1625. 10.1001/jama.1997.03550190090053.CrossRefPubMed Blumenthal D: The future of quality measurement and management in a transforming health care system. JAMA. 1997, 278: 1622-1625. 10.1001/jama.1997.03550190090053.CrossRefPubMed
22.
go back to reference Cucchetti A, Vivarelli M, Heaton ND, Phillips S, Piscaglia F, Bolondi L, La Barba G, Foxton MR, Rela M, O'Grady J, Pinna AD: Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut. 2007, 56: 253-258. 10.1136/gut.2005.084434.CrossRefPubMed Cucchetti A, Vivarelli M, Heaton ND, Phillips S, Piscaglia F, Bolondi L, La Barba G, Foxton MR, Rela M, O'Grady J, Pinna AD: Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut. 2007, 56: 253-258. 10.1136/gut.2005.084434.CrossRefPubMed
23.
go back to reference Banerjee R, Das A, Ghoshal UC, Sinha M: Predicting mortality in patients with cirrhosis of liver with application of neural network technology. J Gastroenterol Hepatol. 2003, 18: 1054-1060. 10.1046/j.1440-1746.2003.03123.x.CrossRefPubMed Banerjee R, Das A, Ghoshal UC, Sinha M: Predicting mortality in patients with cirrhosis of liver with application of neural network technology. J Gastroenterol Hepatol. 2003, 18: 1054-1060. 10.1046/j.1440-1746.2003.03123.x.CrossRefPubMed
24.
go back to reference Aubé C, Winkfield B, Oberti F, Vuillemin E, Rousselet MC, Caron C, Calès P: New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol. 2004, 16: 743-751. 10.1097/01.meg.0000108357.41221.e5.CrossRefPubMed Aubé C, Winkfield B, Oberti F, Vuillemin E, Rousselet MC, Caron C, Calès P: New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis. Eur J Gastroenterol Hepatol. 2004, 16: 743-751. 10.1097/01.meg.0000108357.41221.e5.CrossRefPubMed
25.
go back to reference Afdhal NH, Nunes D: Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004, 99: 1160e74-CrossRef Afdhal NH, Nunes D: Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004, 99: 1160e74-CrossRef
Metadata
Title
Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography
Authors
Li Zhang
Qiao-ying LI
Yun-you Duan
Guo-zhen Yan
Yi-lin Yang
Rui-jing Yang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2012
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/1472-6947-12-55

Other articles of this Issue 1/2012

BMC Medical Informatics and Decision Making 1/2012 Go to the issue